vs
Healthpeak Properties（DOC）与优尼威尔（DSGR）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是优尼威尔的1.4倍（$702.9M vs $518.0M），Healthpeak Properties净利率更高（51.6% vs 1.2%，领先50.4%），优尼威尔同比增速更快（10.7% vs -6.6%），过去两年优尼威尔的营收复合增速更高（13.1% vs 0.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
优尼威尔解决方案公司是一家全球化化学品与原料分销商，同时可为客户提供各类增值服务，业务网络覆盖全球多个地区，在化工及原料分销领域拥有丰富的行业经验与资源积累。
DOC vs DSGR — 直观对比
营收规模更大
DOC
是对方的1.4倍
$518.0M
营收增速更快
DSGR
高出17.3%
-6.6%
净利率更高
DOC
高出50.4%
1.2%
两年增速更快
DSGR
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $518.0M |
| 净利润 | $363.0M | $6.5M |
| 毛利率 | — | 32.9% |
| 营业利润率 | 0.7% | 4.6% |
| 净利率 | 51.6% | 1.2% |
| 营收同比 | -6.6% | 10.7% |
| 净利润同比 | 28.3% | -70.6% |
| 每股收益（稀释后） | $0.28 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCDSGR
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | — | ||
| Q3 25 | $705.9M | $518.0M | ||
| Q2 25 | $694.3M | $502.4M | ||
| Q1 25 | $702.9M | $478.0M | ||
| Q4 24 | $698.0M | $480.5M | ||
| Q3 24 | $700.4M | $468.0M | ||
| Q2 24 | $695.5M | $439.5M |
净利润DOCDSGR
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | — | ||
| Q3 25 | $-117.1M | $6.5M | ||
| Q2 25 | $31.7M | $5.0M | ||
| Q1 25 | $42.8M | $3.3M | ||
| Q4 24 | $4.5M | $-25.9M | ||
| Q3 24 | $85.9M | $21.9M | ||
| Q2 24 | $146.0M | $1.9M |
毛利率DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | 32.9% | ||
| Q2 25 | 60.2% | 33.9% | ||
| Q1 25 | 61.1% | 34.3% | ||
| Q4 24 | 60.3% | 33.3% | ||
| Q3 24 | 60.0% | 33.9% | ||
| Q2 24 | 60.6% | 34.5% |
营业利润率DOCDSGR
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | — | ||
| Q3 25 | 9.2% | 4.6% | ||
| Q2 25 | 5.7% | 5.3% | ||
| Q1 25 | 7.7% | 4.2% | ||
| Q4 24 | -2.2% | 4.2% | ||
| Q3 24 | 14.1% | 4.0% | ||
| Q2 24 | 22.3% | 3.2% |
净利率DOCDSGR
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | — | ||
| Q3 25 | -16.6% | 1.2% | ||
| Q2 25 | 4.6% | 1.0% | ||
| Q1 25 | 6.1% | 0.7% | ||
| Q4 24 | 0.7% | -5.4% | ||
| Q3 24 | 12.3% | 4.7% | ||
| Q2 24 | 21.0% | 0.4% |
每股收益（稀释后）DOCDSGR
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | — | ||
| Q3 25 | $-0.17 | $0.14 | ||
| Q2 25 | $0.05 | $0.11 | ||
| Q1 25 | $0.06 | $0.07 | ||
| Q4 24 | $0.02 | $-0.55 | ||
| Q3 24 | $0.12 | $0.46 | ||
| Q2 24 | $0.21 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $69.2M |
| 总债务越低越好 | — | $665.5M |
| 股东权益账面价值 | $7.8B | $653.9M |
| 总资产 | $21.6B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 1.02× |
8季度趋势，按日历期对齐
现金及短期投资DOCDSGR
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | — | ||
| Q3 25 | $91.0M | $69.2M | ||
| Q2 25 | $89.4M | $47.4M | ||
| Q1 25 | $70.6M | $65.4M | ||
| Q4 24 | $119.8M | $66.5M | ||
| Q3 24 | $180.4M | $61.3M | ||
| Q2 24 | $106.9M | $46.8M |
总债务DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | $665.5M | ||
| Q2 25 | $9.0B | $675.0M | ||
| Q1 25 | $8.9B | $712.4M | ||
| Q4 24 | $8.7B | $693.9M | ||
| Q3 24 | $8.6B | $704.1M | ||
| Q2 24 | $8.6B | $573.7M |
股东权益DOCDSGR
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | — | ||
| Q3 25 | $7.6B | $653.9M | ||
| Q2 25 | $7.9B | $649.4M | ||
| Q1 25 | $8.2B | $636.7M | ||
| Q4 24 | $8.4B | $640.5M | ||
| Q3 24 | $8.6B | $680.8M | ||
| Q2 24 | $8.8B | $653.3M |
总资产DOCDSGR
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | — | ||
| Q3 25 | $19.6B | $1.8B | ||
| Q2 25 | $19.8B | $1.8B | ||
| Q1 25 | $19.8B | $1.8B | ||
| Q4 24 | $19.9B | $1.7B | ||
| Q3 24 | $20.0B | $1.8B | ||
| Q2 24 | $20.2B | $1.6B |
负债/权益比DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | 1.02× | ||
| Q2 25 | 1.14× | 1.04× | ||
| Q1 25 | 1.08× | 1.12× | ||
| Q4 24 | 1.04× | 1.08× | ||
| Q3 24 | 1.00× | 1.03× | ||
| Q2 24 | 0.98× | 0.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $38.4M |
| 自由现金流经营现金流 - 资本支出 | — | $32.9M |
| 自由现金流率自由现金流/营收 | — | 6.3% |
| 资本支出强度资本支出/营收 | 3.4% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 5.95× |
| 过去12个月自由现金流最近4个季度 | — | $92.2M |
8季度趋势，按日历期对齐
经营现金流DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $315.0M | $38.4M | ||
| Q2 25 | $363.5M | $33.3M | ||
| Q1 25 | $279.4M | $-4.8M | ||
| Q4 24 | $1.1B | $45.7M | ||
| Q3 24 | $318.2M | $-17.3M | ||
| Q2 24 | $316.2M | $21.4M |
自由现金流DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | $32.9M | ||
| Q2 25 | — | $28.7M | ||
| Q1 25 | — | $-10.4M | ||
| Q4 24 | $333.7M | $41.1M | ||
| Q3 24 | — | $-20.5M | ||
| Q2 24 | — | $18.0M |
自由现金流率DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -2.2% | ||
| Q4 24 | 47.8% | 8.6% | ||
| Q3 24 | — | -4.4% | ||
| Q2 24 | — | 4.1% |
资本支出强度DOCDSGR
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 105.6% | 1.0% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.8% |
现金转化率DOCDSGR
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | 5.95× | ||
| Q2 25 | 11.48× | 6.66× | ||
| Q1 25 | 6.52× | -1.46× | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | -0.79× | ||
| Q2 24 | 2.17× | 11.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
